Trial Condition(s):
Biological Availability, Postmenopause, Hormone Replacement Therapy
Study to compare the bioavailability of estriol after single oral administration of the two estriol-containing preparations in postmenopausal women
Bayer Identifier:
91130
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
Please see attached Study Results Summary below.
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
24
Trial Dates
Phase
1
Could I receive a placebo?
No
Products
Estriol (E3)
Accepts Healthy Volunteers
N/A
Where to Participate
Locations
| Locations |
|---|
Trial Design
Open-label, randomized, two-way crossover study to compare the bioavailability of estriol after single oral administration of the two estriolcontaining preparations Estriol 2 mg JENAPHARM® and a microcrystalline estriol suspension in 24 healthy postmenopausal volunteers
Trial Type:
Interventional
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
N/A
Primary Outcome
- Timeframe:
Secondary Outcome
- Timeframe:
Additional Information
Copyright © Bayer
Powered by
